← Back to trade feed
ARQT Buy
Gilbert CisnerosDemocrat · CA-31 · HouseTraded May 29, 2026Notified Jun 5, 2026
Trade details
| Amount | $1,001 – $15,000 |
| Asset | Filing ID #20034713 Type Date Notification Date Amount Cap. Gains > Arcutis Biotherapeutics, Inc. - Common stock (ARQT) [ST] (ST) |
| Issuer | Arcutis Biotherapeutics, Inc. |
| Disclosure | 2026 PTR |
What happened next
Stock performance after the trade and after the disclosure became public, compared with SPY, an S&P 500 ETF.
Historical market data is not connected yet.
Conflict Score
0
No mapped overlap
Committee–industry overlap. The explanation and original filing are available below.
Why this score
- No oversight overlap was identified between Rep. Gilbert Cisneros (D-CA) and Filing ID #20034713 Type Date Notification Date Amount Cap. Gains > Arcutis Biotherapeutics, Inc. - Common stock (ARQT) [ST].
- The member's committee jurisdictions do not map to the traded issuer's sector or specific oversight domains.
Powered by the base rules engine. Modifiers (trade size, timing, owner, options) are layered in a later release.
What do the scores mean? Committee–industry overlap
- 65
- Direct jurisdiction
- 50
- Subcommittee
- 30
- Sector overlap
- 18
- Broad jurisdiction
- 0
- No mapped overlap
- —
- Not scored · missing data
The current base model tops out at 65 on a reserved 0–100 scale. Scores are not probabilities or findings of wrongdoing. Zero means no overlap in our mapping, not an absence of all possible conflicts. Read the methodology →
Original extracted asset text
Filing ID #20034713 Type Date Notification Date Amount Cap. Gains > Arcutis Biotherapeutics, Inc. - Common stock (ARQT) [ST]
Extraction may include form headers. The linked original filing is authoritative.